EASO is pleased to support a new 5 year EU-funded H2020 initiative. The TIMESPAN project, led by scientific coordinator Professor Henrik Larsson (Örebro University), includes 17 partners from across academia, industry, and patient advocacy communities, to foster improvement in clinical management of adults living with with ADHD and cooccurring cardiometabolic disease, including obesity.
Emerging evidence points to a significant association and shared genetic traits between adult attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic conditions, including obesity, type 2 diabetes, and cardiovascular diseases.
Various national guidelines on cardiometabolic disease highlight the importance of concurrent psychiatric disorders, but there is a lack of knowledge around ADHD. TIMESPAN seeks to improve clinical outcomes, as well as Quality of life in adult patients with co-occurring cardiometabolic disease.
Adults with ADHD are invited to join and upcoming focus group discussion to provide feedback on a new remote technology study which uses smart phones and wearable devices to follow adults currently on ADHD clinical waiting lists.
Learn more and apply: ART@kcl.ac.uk